Systems and methods for leadless pacing and shock therapy

Patent metadata

Field	Value
Publication number	US-2025082940-A1
Application number	US-202418956991-A
Country	US
Kind code	A1
Filing date	Nov 22, 2024
Priority date	Jan 31, 2013
Publication date	Mar 13, 2025
Grant date	—

Abstract

Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.

First claim

1 - 20 . (canceled)

21 . A system comprising:
a subcutaneous implantable cardioverter-defibrillator (SICD) configured to be implanted within a patient, wherein the SICD comprises:
sensing circuitry configured to sense electrical signals associated with a heart of the patient; and
processing circuitry configured to:
detect, based on at least a portion of the electrical signals, a treatable rhythm;
control the SICD to transmit, during a refractory period of a cardiac cycle, a communication message to a leadless pacing device (LPD), the communication message requesting that the LPD deliver anti-tachyarrhythmia pacing (ATP) therapy to the heart.

22 . The system of claim 21 , wherein the SICD is configured to operate without receiving communications from the LPD.

23 . The system of claim 21 , wherein the SICD comprises a shock module, and wherein the processing circuitry is configured to charge the shock module in parallel with controlling the SICD to transmit the communication message.

24 . The system of claim 21 , wherein the communication message is a first communication message, and wherein the processing circuitry is configured to:
determine, based on the electrical signals, that ATP therapy delivered by the LPD is not effective, and responsive to determining that the ATP therapy is not effective, controlling the SICD to transmit a second communication message to the LPD that requests the LPD to deliver subsequent ATP therapy with a change to one or more parameters that defines the subsequent ATP therapy.

25 . The system of claim 24 , wherein the one or more parameters comprises a duration of the subsequent ATP therapy.

26 . The system of claim 21 , wherein the treatable rhythm comprises a tachyarrhythmia.

27 . The system of claim 21 , wherein the communication message comprises a plurality of electrical signals, and wherein the system further comprises a signal generator configured to deliver the plurality of electrical signals of the communication message via implanted electrodes during the refractory period.

28 . The system of claim 21 , wherein the processing circuitry is configured to control the SICD to transmit a plurality of communication messages requesting respective ATP therapy events before delivering a shock to the patient, wherein the plurality of communication messages comprises the communication message.

29 . The system of claim 21 , wherein the processing circuitry is configured to control the SICD to start a blanking period that controls the sensing circuitry from sensing the electrical signals during delivery of the ATP therapy by the LPD.

30 . The system of claim 21 , further comprising the LPD, wherein the LPD comprises LPD processing circuity, a sensing module, and a signal generator, wherein the sensing module is configured to receive the communication message via electrodes of the LPD, and wherein the LPD processing circuitry is configured to:
control the sensing module to receive, via the electrodes of the LPD, the communication message from the SICD; and control the signal generator to deliver the ATP therapy to the heart.

31 . The system of claim 21 , further comprising a lead configured to be coupled to the SICD and including a plurality of electrodes, wherein the SICD further comprises a signal generator configured to deliver a plurality of electrical pulses via at least one electrode of the plurality of electrodes, and wherein the processing circuitry is configured to control the signal generator to transmit the communication message to the LPD as one or more electrical pulses of the plurality of electrical pulses delivered via at least one of the plurality of electrodes.

32 . A method comprising:
sensing, by sensing circuitry of a subcutaneous implantable cardioverter-defibrillator (SICD) configured to be implanted within a patient, electrical signals associated with a heart of the patient; detecting, by processing circuitry and based on at least a portion of the electrical signals, a treatable rhythm; and controlling, by the processing circuitry, the SICD to transmit, during a refractory period of a cardiac cycle, a communication message to a leadless pacing device (LPD), the communication message requesting that the LPD deliver anti-tachyarrhythmia pacing (ATP) therapy to the heart.

33 . The method of claim 32 , wherein the SICD is configured to operate without receiving communications from the LPD.

34 . The method of claim 32 , further comprising charging, by the processing circuitry, a shock module of the SICD in parallel with controlling the SICD to transmit the communication message.

35 . The method of claim 32 , wherein the communication message is a first communication message, and wherein the method further comprises:
determining, based on the electrical signals, that ATP therapy delivered by the LPD is not effective, and responsive to determining that the ATP therapy is not effective, controlling the SICD to transmit a second communication message to the LPD that requests the LPD to deliver subsequent ATP therapy with a change to one or more parameters that defines the subsequent ATP therapy.

36 . The method of claim 35 , wherein the one or more parameters comprises a duration of the subsequent ATP therapy.

37 . The method of claim 32 , wherein the treatable rhythm comprises a tachyarrhythmia.

38 . The method of claim 32 , wherein controlling the SICD to transmit, during the refractory period, the communication message comprises controlling a signal generator of the SICD to transmit a plurality of electrical pulses of the communication message via implanted electrodes during the refractory period.

39 . The method of claim 32 , further comprising controlling the SICD to transmit a plurality of communication messages requesting respective ATP therapy events before delivering a shock to the patient, wherein the plurality of communication messages comprises the communication message.

40 . The method of claim 32 , further comprising controlling the SICD to start a blanking period that controls the sensing circuitry from sensing the electrical signals during delivery of the ATP therapy by the LPD.

41 . The method of claim 32 , further comprising:
controlling, by LPD processing circuitry of the LPD, a sensing module of the LPD to receive the communication message from the SICD; and controlling, by the LPD processing circuitry, a signal generator of the LPD to deliver the ATP therapy to the heart.

42 . The method of claim 32 , further comprising controlling a signal generator of the SICD to transmit the communication message to the LPD as one or more electrical pulses of a plurality of electrical pulses delivered via at least one of the plurality of electrodes of a lead coupled to the SICD.

43 . A system comprising:
a lead including a plurality of electrodes and configured to be implanted within a patient; an implantable cardioverter-defibrillator (ICD) configured to be coupled to the lead and to be implanted within a patient, wherein the ICD comprises:
sensing circuitry configured to sense electrical signals associated with a heart of the patient via at least one of the plurality of electrodes; and
a signal generator configured to deliver electrical pulses via at least one of the plurality of electrodes; and
processing circuitry configured to:
detect, based on at least a portion of the sensed electrical signals, a treatable rhythm;
control the signa

Assignees

• Medtronic Inc

Inventors

• Greenhut Saul E
• Nehls Robert J
• Olson Walter H
• Zhang Xusheng
• Demmer Wade M
• Jackson Troy E
• Reinke James D

Classifications

• A61N1/36585

  controlled by two or more physical parameters · CPC title

• A61N1/056

  Transvascular endocardial electrode systems · CPC title

• A61N1/3987

  characterised by the timing or triggering of the shock · CPC title

• A61N1/3756

  Casings with electrodes thereon, e.g. leadless stimulators · CPC title

• A61N1/37288

  Communication to several implantable medical devices within one patient · CPC title